Abstract
Importance: The origins and development of autism spectrum disorder (ASD) remain unresolved. No individual-level study has provided estimates of additive genetic, maternal, and environmental effects in ASD across several countries. Objective: To estimate the additive genetic, maternal, and environmental effects in ASD. Design, Setting, and Participants: Population-based, multinational cohort study including full birth cohorts of children from Denmark, Finland, Sweden, Israel, and Western Australia born between January 1, 1998, and December 31, 2011, and followed up to age 16 years. Data were analyzed from September 23, 2016 through February 4, 2018. Main Outcomes and Measures: Across 5 countries, models were fitted to estimate variance components describing the total variance in risk for ASD occurrence owing to additive genetics, maternal, and shared and nonshared environmental effects. Results: The analytic sample included 2001631 individuals, of whom 1027546 (51.3%) were male. Among the entire sample, 22156 were diagnosed with ASD. The median (95% CI) ASD heritability was 80.8% (73.2%-85.5%) for country-specific point estimates, ranging from 50.9% (25.1%-75.6%) (Finland) to 86.8% (69.8%-100.0%) (Israel). For the Nordic countries combined, heritability estimates ranged from 81.2% (73.9%-85.3%) to 82.7% (79.1%-86.0%). Maternal effect was estimated to range from 0.4% to 1.6%. Estimates of genetic, maternal, and environmental effects for autistic disorder were similar with ASD. Conclusions and Relevance: Based on population data from 5 countries, the heritability of ASD was estimated to be approximately 80%, indicating that the variation in ASD occurrence in the population is mostly owing to inherited genetic influences, with no support for contribution from maternal effects. The results suggest possible modest differences in the sources of ASD risk between countries..
Original language | English |
---|---|
Pages (from-to) | 1035-1043 |
Number of pages | 9 |
Journal | JAMA Psychiatry |
Volume | 76 |
Issue number | 10 |
DOIs | |
State | Published - 1 Oct 2019 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2019 American Medical Association. All rights reserved.
Funding
Funding/Support: This study was supported by grant HD073978 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Environmental Health Sciences, and National Institute of Neurological Disorders and Stroke; and the Beatrice and Samuel A. Seaver Foundation (Dr Sandin is a Seaver Faculty Fellow). Dr Leonard is a National Health and Medical Research Council Senior Research Fellow. Data from Israel were ascertained through Israel Science Foundation grant 130/13. reported receiving grants from NIH sub-contract during the conduct of the study. Dr Sourander reported receiving grants from Academy of Finland Flagship Programme (decision No. 320162), Academy of Finland (decision No. 308552), the National Institutes of Health (NIH; W81XWH-17-1-0566 ), and the NIH (1U01HD073978-01) during the conduct of the study. Dr Francis reported receiving grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute of Environmental Health Sciences, and the National Institute of Neurological Disorders and Stroke during the conduct of the study. Ms Yoffe reported employment with the Israeli Ministry of Health, which did not fund the current research. Dr Leonard reported being a National Health and Medical Research Council Senior Research Fellow. Dr Buxbaum reported receiving grants from the Seaver Foundation during the conduct of the study. Dr Wong reported receiving grants from the NIH during the conduct of the study and grants from NHMRC outside the submitted work. Dr Breshnahan reported receiving grants from Columbia University during the conduct of the study. Dr Levine reported receiving research support from Shire Pharmaceuticals unrelated to the current research more than 3 years ago. Dr Sandin reported receiving grants from NIH during the conduct of the study. Dr Sandin reported being a Faculty Fellow of the Beatrice and Samuel A. Seaver Foundation. No other disclosures were reported.
Funders | Funder number |
---|---|
National Institutes of Health | 1U01HD073978-01, W81XWH-17-1-0566 |
National Institute of Neurological Disorders and Stroke | |
National Institute of Environmental Health Sciences | |
Eunice Kennedy Shriver National Institute of Child Health and Human Development | |
Beatrice and Samuel A. Seaver Foundation | |
National Health and Medical Research Council | |
Academy of Finland | 308552, 320162 |
Israel Science Foundation | 130/13 |